Borisy Alexis
SEC-identified person · CIK 1319446 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Revolution Medicines, Inc. RVMD | Director | filed 2020 - 2026 |
| Parabilis Medicines, Inc. PBLS | Director | filed 2026 - 2026 |
| Relay Therapeutics, Inc. RLAY | Director | filed 2020 - 2026 |
| Blueprint Medicines Corp BPMC | Director | filed 2015 - 2025 |
| Tango Therapeutics, Inc. TNGX | Director | filed 2021 - 2025 |
| Eqrx, Inc. EQRX | Director · Executive Chairman | filed 2021 - 2023 |
| Exegenics Inc OPK | Director | filed 2022 - 2023 |
| Magenta Therapeutics, Inc. MGTA | Director | filed 2018 - 2021 |
| Foundation Medicine, Inc. FMI | Director | filed 2013 - 2018 |
| Editas Medicine, Inc. EDIT | Director | filed 2016 - 2017 |
| Zalicus Inc. ZLCS | Director · President and CEO | filed 2006 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.